ECTMX
Price
$16.26
Change
-$0.03 (-0.18%)
Updated
Jun 5 closing price
Net Assets
880.27M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

ECTMX vs RMEBX

Header iconECTMX vs RMEBX Comparison
Open Charts ECTMX vs RMEBXBanner chart's image
Eaton Vance Dividend Builder C
Price$16.26
Change-$0.03 (-0.18%)
VolumeN/A
Net Assets880.27M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
ECTMX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECTMX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECTMX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. ECTMX (880M). RMEBX pays higher dividends than ECTMX: RMEBX (1.16) vs ECTMX (0.74). ECTMX was incepted earlier than RMEBX: ECTMX (32 years) vs RMEBX (11 years). ECTMX (1.74) is less costly to investors than RMEBX (1.07). ECTMX is a more actively managed with annual turnover of: 50.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than ECTMX: RMEBX (250) vs ECTMX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. ECTMX (4.16). RMEBX return over 5 years is better than : 49.85 vs. ECTMX (10.32).
ECTMXRMEBXECTMX / RMEBX
Total Expense Ratio1.741.07163%
Annual Report Gross Expense Ratio1.741.07163%
Fund Existence32 years11 years-
Gain YTD1.9975.34937%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets880M105B1%
Annual Yield % from dividends0.741.1664%
Returns for 1 year4.168.3050%
Returns for 3 years-9.2317.96-51%
Returns for 5 years10.3249.8521%
Returns for 10 years18.3168.2127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA